← SynDRA
PX-478 Free Base
SynDRA canonical compound SYN2073374 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | HIF1A |
|---|
| Mechanism of action | hypoxia inducible factor inhibitor |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- COMT
- GAMT
- GNMT
- HNMT
- KSYK
- NNMT
- NSD2
- NTM1A
- NTMT1
- PNMT
- SYK
Cross-references
Synonyms
- UNII-55OBY93SEP
- RefChem:177359
- DTXCID90141178
- Melphalan N-oxide
- SCHEMBL16158791
- BDBM50231387
- NCGC00384198-01
- NS00068494
- BRD-K36394566-300-01-0
- px-478
- PX-478 HCl
- GLXC-05986
- HY-10231
- orb1300310
- AS-76128
- AKOS030231369
- T23U22X160
- EX-A4655
- UNII-T23U22X160
- CS-5164
- s7612
- C13H20Cl4N2O3
- DTXCID50141179
- CCG-268582
- AC-35272
- DA-57245
- Px 478
- SCHEMBL18548830
- Px-478
- PX-478 2HCL?
- RefChem:177358
- PX478
- PX-478 2HCl
- PX 478 [WHO-DD]
- KCB89844
- PX-478 dihydrochloride
- PX478 cpd
Look up PX-478 Free Base in the interactive SynDRA portal →